Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-013481

Director sold 31,902 shares at an average $41.45 ($1,322,217)

From the SEC's structured data for this filing

Trades in this filing

Brenner Malcolm · Director

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-19 Sale : show line 1 in the form −11,990 $41.78 $500,935 988,531 I
2021-02-22 Sale : show line 2 in the form −2,334 $41.58 $97,054 986,197 I
2021-02-22 Sale : show line 3 in the form −8,779 $42.80 $375,746 977,418 I
2021-02-22 Sale : show line 4 in the form −310 $43.38 $13,446 977,108 I
2021-02-23 Sale : show line 5 in the form −2,800 $38.75 $108,499 974,308 I
2021-02-23 Sale : show line 6 in the form −3,688 $39.46 $145,529 970,620 I
2021-02-23 Sale : show line 7 in the form −1,801 $40.40 $72,769 968,819 I
2021-02-23 Sale : show line 8 in the form −200 $41.19 $8,238 968,619 I
Open-market sales · 31,902 sh · avg $41.45 · $1,322,217
Loading xslF345X03/doc4.xml…